series-c-plus
Stage
5
Investors
About
Themis Bioscience develops viral-vector vaccine platforms and vaccine candidates aimed at infectious diseases, advancing these from preclinical to clinical trial stages using live-attenuated/viral vector technology.
Explore Themis Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.